EMEA (Europe, Middle East and Africa) Anti-Obesity Drugs Market Report 2018

Date : Apr 2018

Formats :
Report Code : PMR13642551

Category : Pharmaceutical and Healthcare
No Of Pages :
In this report, the EMEA AntiObesity Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales K Units, revenue Million USD, market share and growth rate of AntiObesity Drugs for these regions, from 2013 to 2025 forecast
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA AntiObesity Drugs market competition by top manufacturers/players, with AntiObesity Drugs sales volume K Units, price USD/Unit, revenue Million USD and market share for each manufacturer/player; the top players including
Pfizer
Merck
F.HoffmannLa Roche
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
Orexigen Therapeutics
Vivus
Alizyme
Rhythm Pharmaceuticals
Shionogi
Zafgan

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Prescription Drugs
OTC drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
618 Callant
1830 Adult
3060MiddleAged
Others

If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents

EMEA Europe, Middle East and Africa AntiObesity Drugs Market Report 2018
1 AntiObesity Drugs Overview
1.1 Product Overview and Scope of AntiObesity Drugs
1.2 Classification of AntiObesity Drugs
1.2.1 EMEA AntiObesity Drugs Market Size Sales Comparison by Type 20132025
1.2.2 EMEA AntiObesity Drugs Market Size Sales Market Share by Type Product Category in 2017
1.2.3 Prescription Drugs
1.2.4 OTC drugs
1.3 EMEA AntiObesity Drugs Market by Application/End Users
1.3.1 EMEA AntiObesity Drugs Sales Volume and Market Share Comparison by Application 20132025
1.3.2 618 Callant
1.3.3 1830 Adult
1.3.4 3060MiddleAged
1.3.5 Others
1.4 EMEA AntiObesity Drugs Market by Region
1.4.1 EMEA AntiObesity Drugs Market Size Value Comparison by Region 20132025
1.4.2 Europe Status and Prospect 20132025
1.4.3 Middle East Status and Prospect 20132025
1.4.4 Africa Status and Prospect 20132025
1.5 EMEA Market Size Value and Volume of AntiObesity Drugs 20132025
1.5.1 EMEA AntiObesity Drugs Sales and Growth Rate 20132025
1.5.2 EMEA AntiObesity Drugs Revenue and Growth Rate 20132025

2 EMEA AntiObesity Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA AntiObesity Drugs Market Competition by Players/Manufacturers
2.1.1 EMEA AntiObesity Drugs Sales Volume and Market Share of Major Players 20132018
2.1.2 EMEA AntiObesity Drugs Revenue and Share by Players 20132018
2.1.3 EMEA AntiObesity Drugs Sale Price by Players 20132018
2.2 EMEA AntiObesity Drugs Volume and Value by Type/Product Category
2.2.1 EMEA AntiObesity Drugs Sales and Market Share by Type 20132018
2.2.2 EMEA AntiObesity Drugs Revenue and Market Share by Type 20132018
2.2.3 EMEA AntiObesity Drugs Sale Price by Type 20132018
2.3 EMEA AntiObesity Drugs Volume by Application
2.4 EMEA AntiObesity Drugs Volume and Value by Region
2.4.1 EMEA AntiObesity Drugs Sales and Market Share by Region 20132018
2.4.2 EMEA AntiObesity Drugs Revenue and Market Share by Region 20132018
2.4.3 EMEA AntiObesity Drugs Sales Price by Region 20132018

3 Europe AntiObesity Drugs Volume, Value and Sales Price, by Players, Countries, Type and Application
3.1 Europe AntiObesity Drugs Sales and Value 20132018
3.1.1 Europe AntiObesity Drugs Sales Volume and Growth Rate 20132018
3.1.2 Europe AntiObesity Drugs Revenue and Growth Rate 20132018
3.2 Europe AntiObesity Drugs Sales and Market Share by Type
3.3 Europe AntiObesity Drugs Sales and Market Share by Application
3.4 Europe AntiObesity Drugs Sales Volume and Value Revenue by Countries
3.4.1 Europe AntiObesity Drugs Sales Volume by Countries 20132018
3.4.2 Europe AntiObesity Drugs Revenue by Countries 20132018
3.4.3 Germany AntiObesity Drugs Sales and Growth Rate 20132018
3.4.4 France AntiObesity Drugs Sales and Growth Rate 20132018
3.4.5 UK AntiObesity Drugs Sales and Growth Rate 20132018
3.4.6 Russia AntiObesity Drugs Sales and Growth Rate 20132018
3.4.7 Italy AntiObesity Drugs Sales and Growth Rate 20132018
3.4.8 Benelux AntiObesity Drugs Sales and Growth Rate 20132018

4 Middle East AntiObesity Drugs Volume, Value and Sales Price, by Region, Type and Application
4.1 Middle East AntiObesity Drugs Sales and Value 20132018
4.1.1 Middle East AntiObesity Drugs Sales Volume and Growth Rate 20132018
4.1.2 Middle East AntiObesity Drugs Revenue and Growth Rate 20132018
4.2 Middle East AntiObesity Drugs Sales and Market Share by Type
4.3 Middle East AntiObesity Drugs Sales and Market Share by Application
4.4 Middle East AntiObesity Drugs Sales Volume and Value Revenue by Countries
4.4.1 Middle East AntiObesity Drugs Sales Volume by Countries 20132018
4.4.2 Middle East AntiObesity Drugs Revenue by Countries 20132018
4.4.3 Saudi Arabia AntiObesity Drugs Sales and Growth Rate 20132018
4.4.4 Israel AntiObesity Drugs Sales and Growth Rate 20132018
4.4.5 UAE AntiObesity Drugs Sales and Growth Rate 20132018
4.4.6 Iran AntiObesity Drugs Sales and Growth Rate 20132018

5 Africa AntiObesity Drugs Volume, Value and Sales Price by Players, Countries, Type and Application
5.1 Africa AntiObesity Drugs Sales and Value 20132018
5.1.1 Africa AntiObesity Drugs Sales Volume and Growth Rate 20132018
5.1.2 Africa AntiObesity Drugs Revenue and Growth Rate 20132018
5.2 Africa AntiObesity Drugs Sales and Market Share by Type
5.3 Africa AntiObesity Drugs Sales and Market Share by Application
5.4 Africa AntiObesity Drugs Sales Volume and Value Revenue by Countries
5.4.1 Africa AntiObesity Drugs Sales Volume by Countries 20132018
5.4.2 Africa AntiObesity Drugs Revenue by Countries 20132018
5.4.3 South Africa AntiObesity Drugs Sales and Growth Rate 20132018
5.4.4 Nigeria AntiObesity Drugs Sales and Growth Rate 20132018
5.4.5 Egypt AntiObesity Drugs Sales and Growth Rate 20132018
5.4.6 Algeria AntiObesity Drugs Sales and Growth Rate 20132018

6 EMEA AntiObesity Drugs Manufacturers/Players Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 AntiObesity Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer AntiObesity Drugs Sales, Revenue, Price and Gross Margin 20132018
6.1.4 Main Business/Business Overview
6.2 Merck
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 AntiObesity Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Merck AntiObesity Drugs Sales, Revenue, Price and Gross Margin 20132018
6.2.4 Main Business/Business Overview
6.3 F.HoffmannLa Roche
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 AntiObesity Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 F.HoffmannLa Roche AntiObesity Drugs Sales, Revenue, Price and Gross Margin 20132018
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 AntiObesity Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 GlaxoSmithKline AntiObesity Drugs Sales, Revenue, Price and Gross Margin 20132018
6.4.4 Main Business/Business Overview
6.5 AstraZeneca
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 AntiObesity Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 AstraZeneca AntiObesity Drugs Sales, Revenue, Price and Gross Margin 20132018
6.5.4 Main Business/Business Overview
6.6 Boehringer Ingelheim
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 AntiObesity Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Boehringer Ingelheim AntiObesity Drugs Sales, Revenue, Price and Gross Margin 20132018
6.6.4 Main Business/Business Overview
6.7 Novo Nordisk
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 AntiObesity Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Novo Nordisk AntiObesity Drugs Sales, Revenue, Price and Gross Margin 20132018
6.7.4 Main Business/Business Overview
6.8 Eisai
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 AntiObesity Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Eisai AntiObesity Drugs Sales, Revenue, Price and Gross Margin 20132018
6.8.4 Main Business/Business Overview
6.9 Norgine
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 AntiObesity Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Norgine AntiObesity Drugs Sales, Revenue, Price and Gross Margin 20132018
6.9.4 Main Business/Business Overview
6.10 Arena Pharmaceuticals
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 AntiObesity Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Arena Pharmaceuticals AntiObesity Drugs Sales, Revenue, Price and Gross Margin 20132018
6.10.4 Main Business/Business Overview
6.11 Orexigen Therapeutics
6.12 Vivus
6.13 Alizyme
6.14 Rhythm Pharmaceuticals
6.15 Shionogi
6.16 Zafgan

7 AntiObesity Drugs Manufacturing Cost Analysis
7.1 AntiObesity Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of AntiObesity Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 AntiObesity Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of AntiObesity Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA AntiObesity Drugs Market Forecast 20182025
11.1 EMEA AntiObesity Drugs Sales, Revenue and Price Forecast 20182025
11.1.1 EMEA AntiObesity Drugs Sales and Growth Rate Forecast 20182025
11.1.2 EMEA AntiObesity Drugs Revenue and Growth Rate Forecast 20182025
11.1.3 EMEA AntiObesity Drugs Price and Trend Forecast 20182025
11.2 EMEA AntiObesity Drugs Sales, Revenue and Growth Rate Forecast by Region 20182025
11.3 Europe AntiObesity Drugs Sales, Revenue and Growth Rate Forecast by Region 20182025
11.4 Middle Eastt AntiObesity Drugs Sales, Revenue and Growth Rate Forecast by Region 20182025
11.5 Africa AntiObesity Drugs Sales, Revenue and Growth Rate Forecast by Region 20182025
11.6 EMEA AntiObesity Drugs Sales Forecast by Type 20182025
11.7 EMEA AntiObesity Drugs Sales Forecast by Application 20182025

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
  Purchase Options for Report

Need More information

Call us :
USA : +1 7162260907
UK : +44 7441952057
....
sales@planetmarketreports.com

Why to PMR

PMR Market Research

Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.

  • Industrial ...
  • Business ....
  • Consumer ....
  • Peer ....